Remove Arrhythmia Remove Electrophysiology Remove Heart Failure
article thumbnail

An approach to fluoroless radiofrequency atrial fibrillation ablation

Frontiers in Cardiovascular Medicine

Atrial fibrillation is the most prevalent arrhythmia with a lifetime risk of nearly 30%. It can be associated with reduced quality of life and complications such as heart failure and stroke. Pulmonary vein isolation (PVI) is the most effective treatment for rhythm control.

article thumbnail

Ion channel trafficking implications in heart failure

Frontiers in Cardiovascular Medicine

Heart failure (HF) is recognized as an epidemic in the contemporary world, impacting around 1%–2% of the adult population and affecting around 6 million Americans. Among the most serious manifestations associated with HF is arrhythmia due to the electrophysiological changes within the cardiomyocyte.

article thumbnail

Divergent electrophysiologic action of dapagliflozin and empagliflozin on ventricular and atrial tachyarrhythmias in isolated rabbit hearts

Frontiers in Cardiovascular Medicine

Background The use of SGLT-2 inhibitors has revolutionized heart failure therapy. Evidence suggests a reduced incidence of ventricular and atrial arrhythmias in patients with dapagliflozin or empagliflozin treatment. Conclusion In this model, empagliflozin and dapagliflozin demonstrated opposite antiarrhythmic properties.

article thumbnail

Restoration of calcium release synchrony: A novel target for heart failure and ventricular arrhythmia

HeartRhythm

Myocardial calcium (Ca2+) signaling plays a crucial role in contractile function and membrane electrophysiology. An abnormal myocardial Ca2+ transient is linked to heart failure and ventricular arrhythmias.

article thumbnail

A fascinating electrophysiology case. What is this wide complex tachycardia, and how best to manage it?

Dr. Smith's ECG Blog

Slow VT below the detection rate of the ICD lead to worsening heart failure and low stroke volume. Post conversion of VT the patient had low output cardiac failure and became unstable and hypoperfused. Cardiac output (CO) was being maintained by the tachycardia. After atrial rhythm/SR was restored the patient slowly improved.

article thumbnail

Cardiac stereotactic radiation therapy for refractory ventricular arrhythmias in patients with left ventricular assist devices

Journal of Cardiovascular Electrophysiology

Abstract Left ventricular assist device (LVAD) implantation is an established treatment for patients with advanced heart failure refractory to medical therapy. However, the incidence of ventricular arrhythmias (VAs) is high in this population, both in the acute and delayed phases after implantation.

article thumbnail

First Heart Rhythm Patients in Southern Italy Treated with Advanced Robotic Technology

DAIC

“As electrophysiologists, our primary goal is to improve the lives of our patients,” said Dr. Mario Volpicelli , Head of the Electrophysiology Unit of the hospital. Robotic Magnetic Navigation introduces the benefits of robotic precision and safety to cardiac ablation, a common minimally invasive procedure to treat arrhythmias.